Products
Online Inquiry
SGLT2-IN-1
Inquiry
Cat. No.:
OB0425LY-264
Synonyms:
864070-37-1; (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-hydroxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; Dapagliflozin metabolite M8; (2S,3R,4R,5S,6R)-2-[4-Chloro-3-[(4-hydroxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
Size:
5 mg; 10 mg; 50 mg; 100 mg
CAS No.:
864070-37-1
Compound CID:
44580555
Specification
Description:
SGLT2-IN-1 is a potent sodium-dependent glucose cotransporter (SGLT2) inhibitor that reduces glucose reabsorption by inhibiting SGLT2 protein in renal tubular epithelial cells.
Formula Weight:
380.82
Applications:
SGLT2-IN-1 can be used to improve insulin sensitivity, help with weight control and reduce cardiovascular risk.
Storage:
Storage at 4°C.
Formula:
C19H21ClO6
Appearance:
Solid
Purity:
99.51%, determined by LC-MS.
Solubility:
DMSO
Pathway:
Membrane transporter/Ion channel
Identity:
Confirmed by NMR and LC-MS.
Target:
SGLT
Library Information
Solubility:
DMSO